Year: 2010
Type: article
Abstract: Lameness in dairy cattle has been reported as a concern for welfare and economic reasons for over 20 years. This concern has been expressed from across the industry and has prompted the launch of a number of initiatives to address the problem. This article reviews the current status of lameness in dairy cows in the UK, outlines the current understanding of the condition and its impacts on welfare and productivity, and highlights areas where evidence is still lacking.
Source: In Practice
DOI: 10.1136/inp.c6672
Authors: Simon Archer, Nick Bell, Jon Huxley
Language: English
Subfield: Animal Science and Zoology
Domain: Life Sciences
SDG: Zero hunger
Open Access status: green
Funders: U.S. Department of Defense, U.S. Department of Veterans Affairs, Cancer Research Institute, Breast Cancer Research Foundation, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Gilead Sciences, Susan G. Komen, Irish Research eLibrary, Cancer Research UK, Royal College of Veterinary Surgeons Charitable Trust, European Commission, National Breast Cancer Foundation, Higher Education Authority, Irish Cancer Society, Science Foundation Ireland, Agence Nationale de la Recherche, Ministerie van Volksgezondheid, Welzijn en Sport, Svenska Sällskapet för Medicinsk Forskning, KU Leuven, Fondation ARC pour la Recherche sur le Cancer, Ligue Contre le Cancer, Peter MacCallum Cancer Centre, KWF Kankerbestrijding, National Institutes of Health, Medical Research Council, Engineering and Physical Sciences Research Council, National Health and Medical Research Council, Japan Society for the Promotion of Science, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, DOD Prostate Cancer Research Program, DOD Peer Reviewed Cancer Research Program
Awards: SYSTEMS BIOLOGY APPROACH TO PREDICTING AND ASSESSING RESPONSE TO CHEMORADIATION FOR BRAIN TUMORS, G1159005989, G1307000385, G1313646905, Tissue resident memory T cells- delineating their role in breast cancer anti-tumor immunity, G1828163000, Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging, G2291306530, CLoud ARtificial Intelligence For pathologY, G2689512122, Precision Oncology Ireland, G3068466812, Methods and Tools for Integrating Pathomics Data into Cancer Registries, G3629664845, G3679001064, G3716872827, Optimal Management of Gender-Specific Cancers via Efficient Use of Protein Profiling, Digital Pathology and Systems Medicine Tools (OPTi-PREDICT), CHIRP Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung Cancers, G4119534169, G434337789, フランス労務審判所(Conseil de Prud'hommes)の研究, TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine, G4876897937, G4904196628, G4950536974, HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identification, MR Fingerprinting and Computerized Decision Support for Prostate Cancer, Computerized histologic image predictor of cancer outcome, PaRis Artificial Intelligence Research InstitutE, Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal Carcinoma, G5850682332, Possible roles of human mast cells in the formation of xanthelasma palpebrarum, NOVEL CT-DERIVED RADIOMIC BIOMARKERS FOR LUNG NODULE CHARACTERIZATION IN THE SCREENING POPULATION, Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients, PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials, Translating molecular pathology into cancer diagnostics, Causal Modelling with Graph Neural Networks for Personalised Medicine in Computational Pathology, QUANTITATIVE VESSEL TORTUOSITY AS BIOMARKER FOR PREDICTING AND MONITORING RESPONSE TO IMMUNOTHERAPY FOR NON-SMALL CELL LUNG CANCER FROM ROUTINE CT SCANS, G7502883741, Institut Q-LIFE, Illuminating the evolutionary history of colorectal cancer metastasis: basic principles and clinical applications, MSK SPORE in Genomic Instability in Breast Cancer, G7935030457, G8166743225, G8600969490, COMPUTATIONAL HISTOMORPHOMETRIC PREDICTOR OF PATHOLOGIC RESPONSE AND DISEASE RECURRENCE FOR TRIPLE-NEGATIVE BREAST CANCER, Prostate cancer risk stratification via computational 3D pathology, Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer, Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC), High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials, Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer, Mayo Clinic Breast Cancer SPORE, An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic Benefit, The Tisch Cancer Institute - Cancer Center Support Grant, G936396391
OpenAlex ID: W2106376595
